AAAAAA
Results: 1-25/32
Authors:
Tenev, T
Marani, M
McNeish, I
Lemoine, NR
Citation: T. Tenev et al., Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasomeinhibitors, CELL DEAT D, 8(3), 2001, pp. 256-264
Authors:
Ghaneh, P
Greenhalf, W
Humphreys, M
Wilson, D
Zumstein, L
Lemoine, NR
Neoptolemos, JP
Citation: P. Ghaneh et al., Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo, GENE THER, 8(3), 2001, pp. 199-208
Authors:
Crnogorac-Jurcevic, T
Efthimiou, E
Capelli, P
Blaveri, E
Baron, A
Terris, B
Jones, M
Tyson, K
Bassi, C
Scarpa, A
Lemoine, NR
Citation: T. Crnogorac-jurcevic et al., Gene expression profiles of pancreatic cancer and stromal desmoplasia, ONCOGENE, 20(50), 2001, pp. 7437-7446
Authors:
El-Hariry, I
Pignatelli, M
Lemoine, NR
Citation: I. El-hariry et al., FGF-1 and FGF-2 regulate the expression of E-cadherin and catenins in pancreatic adenocarcinoma, INT J CANC, 94(5), 2001, pp. 652-661
Authors:
Sirivatanauksorn, V
Sirivatanauksorn, Y
Gorman, PA
Davidson, JM
Sheer, D
Moore, PS
Scarpa, A
Edwards, PAW
Lemoine, NR
Citation: V. Sirivatanauksorn et al., Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping, INT J CANC, 91(3), 2001, pp. 350-358
Authors:
Sirivatanauksorn, Y
Sirivatanauksorn, V
Lemoine, NR
Williamson, RCN
Davidson, BR
Citation: Y. Sirivatanauksorn et al., Genomic homogeneity in fibrolamellar carcinomas, GUT, 49(1), 2001, pp. 82-86
Authors:
Efthimiou, E
Crnogorac-Jurcevic, T
Lemoine, NR
Citation: E. Efthimiou et al., Inherited predisposition to pancreatic cancer, GUT, 48(2), 2001, pp. 143-147
Authors:
Moore, PS
Orlandini, S
Zamboni, G
Capelli, P
Rigaud, G
Falconi, M
Bassi, C
Lemoine, NR
Scarpa, A
Citation: Ps. Moore et al., Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis, BR J CANC, 84(2), 2001, pp. 253-262
Authors:
El-Hariry, I
Pignatelli, M
Lemoine, NR
Citation: I. El-hariry et al., FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines, BR J CANC, 84(12), 2001, pp. 1656-1663
Authors:
Vassaux, G
Lemoine, NR
Citation: G. Vassaux et Nr. Lemoine, Gene therapy for carcinoma of the breast - Genetic toxins, BREAST CA R, 2(1), 2000, pp. 22-27
Authors:
Vile, RG
Russell, SJ
Lemoine, NR
Citation: Rg. Vile et al., Cancer gene therapy: hard lessons and new courses, GENE THER, 7(1), 2000, pp. 2-8
Authors:
Thatcher, NJ
Edwards, RJ
Lemoine, NR
Doehmer, J
Davies, DS
Citation: Nj. Thatcher et al., The potential of acetaminophen as a prodrug in gene-directed enzyme prodrug therapy, CANC GENE T, 7(4), 2000, pp. 521-525
Authors:
Zhao, J
Tenev, T
Martins, LM
Downward, J
Lemoine, NR
Citation: J. Zhao et al., The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner, J CELL SCI, 113(23), 2000, pp. 4363-4371
Authors:
Rigaud, G
Moore, PS
Zamboni, G
Orlandini, S
Taruscio, D
Paradisi, S
Lemoine, NR
Kloppel, G
Scarpa, A
Citation: G. Rigaud et al., Allelotype of pancreatic acinar cell carcinoma, INT J CANC, 88(5), 2000, pp. 772-777
Authors:
Aspinall, RJ
Lemoine, NR
Citation: Rj. Aspinall et Nr. Lemoine, Suicide and the not-so-innocent bystander, GUT, 47(3), 2000, pp. 327-328
Authors:
Scarpa, A
Di Pace, C
Talamini, G
Falconi, M
Lemoine, NR
Iacono, C
Achille, A
Baron, A
Zamboni, G
Citation: A. Scarpa et al., Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis, GUT, 46(6), 2000, pp. 842-848
Authors:
Ogg, GS
Dunbar, PR
Cerundolo, V
McMichael, AJ
Lemoine, NR
Savage, P
Citation: Gs. Ogg et al., Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes, BR J CANC, 82(5), 2000, pp. 1058-1062
Authors:
Pandha, HS
Lemoine, NR
Citation: Hs. Pandha et Nr. Lemoine, Intratumoral gene transfer of the cytosine deaminase gene for the treatment of breast cancer, METH MOL M, 35, 2000, pp. 523-534
Authors:
Lemoine, NR
Glorioso, JC
Citation: Nr. Lemoine et Jc. Glorioso, Gene therapy for the millenium: in with the new, GENE THER, 6(7), 1999, pp. 1199-1199
Authors:
Schmitt, JF
Keogh, MC
Dennehy, U
Chen, D
Lupu, F
Weston, K
Taylor, D
Kakkar, VV
Lemoine, NR
Citation: Jf. Schmitt et al., Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation, GENE THER, 6(6), 1999, pp. 1184-1191
Authors:
Vassaux, G
Hurst, HC
Lemoine, NR
Citation: G. Vassaux et al., Insulation of a conditionally expressed transgene in an adenoviral vector, GENE THER, 6(6), 1999, pp. 1192-1197
Authors:
Keogh, MC
Chen, D
Schmitt, JF
Dennehy, U
Kakkar, VV
Lemoine, NR
Citation: Mc. Keogh et al., Design of a muscle cell-specific expression vector utilising human vascular smooth muscle alpha-actin regulatory elements, GENE THER, 6(4), 1999, pp. 616-628
Authors:
Aspinall, RJ
Lemoine, NR
Citation: Rj. Aspinall et Nr. Lemoine, Gene therapy for pancreatic and biliary malignancies, ANN ONCOL, 10, 1999, pp. 188-192
Authors:
Pandha, HS
Martin, LA
Rigg, A
Hurst, HC
Stamp, GWH
Sikora, K
Lemoine, NR
Citation: Hs. Pandha et al., Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression, J CL ONCOL, 17(7), 1999, pp. 2180-2189
Authors:
Chinswangwatanakul, V
Worthington, T
Lemoine, NR
Williamson, RCN
Kakkar, AK
Citation: V. Chinswangwatanakul et al., Circulating vascular endothelial growth factor correlates with systemic thrombin generation in patients with pancreatic carcinoma, THROMB HAEM, 81(5), 1999, pp. 851-851